CURLF Stock - Curaleaf Holdings, Inc.
Unlock GoAI Insights for CURLF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.28B | $1.37B | $1.22B | $1.19B | $659.74M |
| Gross Profit | $444.98M | $486.43M | $492.56M | $480.43M | $111.58M |
| Gross Margin | 34.8% | 35.5% | 40.2% | 40.5% | 16.9% |
| Operating Income | $19.23M | $43.67M | $62.41M | $58.06M | $-160,211,790 |
| Net Income | $-226,733,626 | $-286,353,819 | $-355,434,685 | $-204,127,936 | $-60,180,624 |
| Net Margin | -17.7% | -20.9% | -29.0% | -17.2% | -9.1% |
| EPS | $-0.29 | $-0.40 | $-0.53 | $-0.16 | $-0.11 |
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of June 16, 2022, it operated 134 dispensaries and 26 cultivation sites in 22 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 31st 2023 | Stifel | Downgrade | Sell | - |
| May 19th 2023 | The Benchmark Company | Downgrade | Hold | - |
| December 2nd 2022 | Wedbush | Initiation | Outperform | - |
| October 28th 2022 | BTIG Research | Resumed | Buy | - |
| July 22nd 2022 | Seaport Research Partners | Initiation | Buy | $9 |
Earnings History & Surprises
CURLFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 2, 2026 | $-0.08 | — | — | — |
Q4 2025 | Nov 5, 2025 | $-0.07 | $-0.06 | +14.3% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $-0.07 | $-0.06 | +14.3% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.07 | $-0.07 | 0.0% | = MET |
Q1 2025 | Mar 3, 2025 | $-0.06 | $0.02 | +133.3% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $-0.06 | $-0.07 | -16.7% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $-0.05 | $-0.06 | -20.0% | ✗ MISS |
Q2 2024 | May 9, 2024 | $-0.06 | $-0.07 | -16.7% | ✗ MISS |
Q1 2024 | Mar 6, 2024 | $-0.06 | $-0.09 | -50.0% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-0.06 | $-0.09 | -50.0% | ✗ MISS |
Q3 2023 | Aug 9, 2023 | $-0.03 | $-0.07 | -136.9% | ✗ MISS |
Q2 2023 | May 1, 2023 | $-0.05 | $-0.23 | -360.0% | ✗ MISS |
Q1 2023 | Mar 28, 2023 | $-0.04 | $-0.38 | -850.9% | ✗ MISS |
Q4 2022 | Nov 7, 2022 | $-0.05 | $-0.07 | -40.0% | ✗ MISS |
Q3 2022 | Aug 8, 2022 | $-0.04 | $-0.04 | -2.6% | ✗ MISS |
Q2 2022 | May 9, 2022 | $-0.02 | $-0.03 | -25.0% | ✗ MISS |
Q1 2022 | Mar 3, 2022 | $-0.03 | $-0.04 | -20.0% | ✗ MISS |
Q4 2021 | Nov 8, 2021 | — | $-0.08 | — | — |
Q3 2021 | Aug 9, 2021 | — | $-0.01 | — | — |
Frequently Asked Questions about CURLF
What is CURLF's current stock price?
What is the analyst price target for CURLF?
What sector is Curaleaf Holdings, Inc. in?
What is CURLF's market cap?
Does CURLF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CURLF for comparison